Cell free DNA: revolution in molecular diagnostics – the journey so far

References

[1] Mandel P, Metais P. Les acides nucleiques du plasma sanguine chez l’homme. CR Acad Sci Paris. 1948;142:241–3.Suche in Google Scholar

[2] Tan EM, Schur PH, Carr RI, Kunkel HG. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 19661;45:1732–40.10.1172/JCI105479Suche in Google Scholar

[3] Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37:646.Suche in Google Scholar

[4] Stroun M, Anker P, Maurice P, Lyautey J, Lederrey C, Beljanski M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 1989;46:318–22.10.1159/000226740Suche in Google Scholar

[5] Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomark Amp Prev. 1994;3:67.Suche in Google Scholar

[6] Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C, Stroun M. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol. 1994;86:774–9.10.1111/j.1365-2141.1994.tb04828.xSuche in Google Scholar

[7] Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 1998;17:89–97.10.1097/00006676-199807000-00012Suche in Google Scholar

[8] Lo YMD, Chan LYS, Lo K-W, Leung S-F, Zhang J, Chan ATC, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 1999;59:1188.Suche in Google Scholar

[9] Anker P, Mulcahy H, Chen XQ, Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev.1999;18:65–73.10.1023/A:1006260319913Suche in Google Scholar

[10] Fournié GJ, Courtin JP, Laval F, Chalé JJ, Pourrat JP, Pujazon MC, et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 1995;91:221–7.10.1016/0304-3835(95)03742-FSuche in Google Scholar

[11] Rogers JC, Boldt D, Kornfeld S, Skinner A, Valeri CR. Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci U S A. 1972;69:1685–9.10.1073/pnas.69.7.1685Suche in Google Scholar PubMed PubMed Central

[12] Mesa MA, Vasquez G. NETosis. Autoimmune Dis. 2013;2013:651497.10.1155/2013/651497Suche in Google Scholar PubMed PubMed Central

[13] Illanes S, Denbow ML, Smith RP, Overton TG, Soothill PW, Finning K. Detection of cell-free fetal DNA in maternal urine. Prenat Diagn. 2006;26:1216–8.10.1002/pd.1591Suche in Google Scholar PubMed

[14] Lu T, Li J. Clinical applications of urinary cell-free DNA in cancer: current insights and promising future. Am J Cancer Res. 2017;7(11):2318–32.Suche in Google Scholar

[15] Lo YMD. Molecular testing of urine: catching DNA on the way out. Clin Chem. 2000;46:1039.10.1093/clinchem/46.8.1039Suche in Google Scholar

[16] Holmgren L, Szeles A, Rajnavölgyi E, Folkman J, Klein G, Ernberg I, et al. Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood. 1999;93:3956.10.1182/blood.V93.11.3956.411k05_3956_3963Suche in Google Scholar

[17] García-Olmo D, García-Olmo DC, Ontañón J, Martinez E, Vallejo M. Tumor DNA circulating in the plasma might play a role in metastasis. The hypothesis of the genometastasis. Histol Histopathol. 1999;14:1159–64.Suche in Google Scholar

[18] Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR. Non-invasive prenatal measurement of the fetal genome. Nature. 2012;487(7407):320-4.10.1038/nature11251Suche in Google Scholar PubMed PubMed Central

[19] Xie G, Hou A, Li L, Gao Y, Cheng S. Quantification of plasma DNA as a screening tool for lung cancer. Chin Med J (Engl). 2004;117:1485–8.Suche in Google Scholar

[20] Xue X, Teare MD, Holen I, Zhu YM, Woll PJ. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. Clin Chim Acta Int J Clin Chem. 2009;404:100–4.10.1016/j.cca.2009.02.018Suche in Google Scholar PubMed

[21] Li J, Harris L, Mamon H, Kulke MH, Liu W-H, Zhu P, et al. Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma. J Mol Diagn. 2006;8:22–30.10.2353/jmoldx.2006.050074Suche in Google Scholar PubMed PubMed Central

[22] Khani M, Pouresmaeili F, Mirfakhraie R. Evaluation of extracted circulating cell free DNA concentration by standard nucleospin plasma XS (NS) kit protocol compared to its modified protocol. Urol Nephrol Open Access. 2017;J4:00137.10.15406/unoaj.2017.04.00137Suche in Google Scholar

[23] Yuan H, Zhu Z-Z, Lu Y, Liu F, Zhang W, Huang G, et al. A modified extraction method of circulating free DNA for epidermal growth factor receptor mutation analysis. Yonsei Med J. 2012;53:132–7.10.3349/ymj.2012.53.1.132Suche in Google Scholar PubMed PubMed Central

[24] Baker M. Digital PCR hits its stride. Nat Methods. 2012;9:541.10.1038/nmeth.2027Suche in Google Scholar

[25] Van den Veyver IB, Patel A, Shaw CA, Pursley AN, Kang SH, Simovich MJ, et al. Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn. 2009;29:29–39.10.1002/pd.2127Suche in Google Scholar PubMed PubMed Central

[26] Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 2012;4:136ra68.10.1126/scitranslmed.3003726Suche in Google Scholar PubMed

[27] Mäbert K, Cojoc M, Peitzsch C, Kurth I, Souchelnytskyi S, Dubrovska A. Cancer biomarker discovery: current status and future perspectives. Int J Radiat Biol. 2014;90:659–77.10.3109/09553002.2014.892229Suche in Google Scholar PubMed

[28] Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 2014;20:548–54.10.1038/nm.3519Suche in Google Scholar PubMed PubMed Central

[29] Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol. 2016;34:547–55.10.1038/nbt.3520Suche in Google Scholar PubMed PubMed Central

[30] Han X, Wang J, Sun Y. Circulating tumor DNA as biomarkers for cancer detection. Biomark Hum Dis Transl Med. 2017;15:59–72.10.1016/j.gpb.2016.12.004Suche in Google Scholar PubMed PubMed Central

[31] Guzzetta AA, Pisanic Ii TR, Sharma P, Yi JM, Stark A, Wang T-H, et al. The promise of methylation on beads for cancer detection and treatment. Expert Rev Mol Diagn. 2014;14:845–52.10.1586/14737159.2014.943665Suche in Google Scholar PubMed PubMed Central

[32] Fackler MJ, Lopez Bujanda Z, Umbricht C, Teo WW, Cho S, Zhang Z, et al. Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res. 2014;74:2160–70.10.1158/0008-5472.CAN-13-3392Suche in Google Scholar PubMed PubMed Central

[33] Drury S, Hill M, Chitty LS. Cell-free fetal DNA testing for prenatal diagnosis. Adv Clin Chem. 2016;76:1-35.10.1016/bs.acc.2016.05.004Suche in Google Scholar PubMed

[34] Mackie F, Hemming K, Allen S, Morris R, Kilby M. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. Br J Obstet Gynaecol. 2016;124:32–46.10.1111/1471-0528.14050Suche in Google Scholar PubMed

[35] Akolekar R, Beta J, Picciarelli G, Ogilvie C, D’Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2014;45:16–26.10.1097/OGX.0000000000000214Suche in Google Scholar

[36] Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883–92.10.1056/NEJMoa1113205Suche in Google Scholar PubMed PubMed Central

[37] Shyamala K, Girish HC, Murgod S. Risk of tumor cell seeding through biopsy and aspiration cytology. J Int Soc Prev Community Dent. 2014;4:5–11.10.4103/2231-0762.129446Suche in Google Scholar PubMed PubMed Central

[38] Corcoran RB, Chabner BA. Application of cell-free DNA analysis to cancer treatment. N Engl J Med. 2018;379:1754–65.10.1056/NEJMra1706174Suche in Google Scholar PubMed

[39] Vymetalkova V, Cervena K, Bartu L, Vodicka P. Circulating cell-free DNA and colorectal cancer: a systematic review. Int J Mol Sci. 2018;19.10.3390/ijms19113356Suche in Google Scholar PubMed PubMed Central

[40] Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem. 2001;47:624.10.1093/clinchem/47.4.624Suche in Google Scholar

[41] Flamini E, Mercatali L, Nanni O, Calistri D, Nunziatini R, Zoli W, et al. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin Cancer Res. 2006;12:6985.10.1158/1078-0432.CCR-06-1931Suche in Google Scholar PubMed

[42] Spindler KG, Boysen AK, Pallisgård N, Johansen JS, Tabernero J, Sørensen MM, et al. Cell-free DNA in metastatic colorectal cancer: a systematic review and meta-analysis. Oncologist. 2017;22:1049–55.10.1634/theoncologist.2016-0178Suche in Google Scholar PubMed PubMed Central

[43] Fernandez-Cuesta L, Perdomo S, Avogbe PH, Leblay N, Delhomme TM, Gaborieau V, et al. Identification of circulating tumor DNA for the early detection of small-cell lung cancer. EBioMedicine. 2016;10:117–23.10.1016/j.ebiom.2016.06.032Suche in Google Scholar PubMed PubMed Central

[44] George J, Lim JS, Jang SJ, Cun Y, Ozretić L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47.10.1038/nature14664Suche in Google Scholar PubMed PubMed Central

[45] Cargnin S, Canonico PL, Genazzani AA, Terrazzino S. Quantitative analysis of circulating cell-free DNA for correlation with lung cancer survival: a systematic review and meta-analysis. J Thorac Oncol. 2017;12:43–53.10.1016/j.jtho.2016.08.002Suche in Google Scholar PubMed

[46] Ponomaryova AA, Rykova EY, Cherdyntseva NV, Skvortsova TE, Dobrodeev AY, Zav’yalov AA, et al. Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients. Lung Cancer. 2013;81:397–403.10.1016/j.lungcan.2013.05.016Suche in Google Scholar PubMed

[47] Mayrhofer M, De Laere B, Whitington T, Van Oyen P, Ghysel C, Ampe J, et al. Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis. Genome Med. 2018;10:85.10.1186/s13073-018-0595-5Suche in Google Scholar PubMed PubMed Central

[48] Azad AA, Volik SV, Wyatt AW, Haegert A, Le Bihan S, Bell RH, et al. Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer. Clin Cancer Res. 2015;21:2315–24.10.1158/1078-0432.CCR-14-2666Suche in Google Scholar PubMed

[49] Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, et al. CpG Island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. The Prostate. 2007;68:42–9.10.1002/pros.20651Suche in Google Scholar PubMed

[50] Sobhani N, Generali D, Zanconati F, Bortul M, Scaggiante B. Cell-free DNA integrity for the monitoring of breast cancer: future perspectives? World J Clin Oncol. 2018;9:26–32.10.5306/wjco.v9.i2.26Suche in Google Scholar PubMed PubMed Central

[51] Burwinkel B MD. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis. Breast Cancer Res Treat. 2014;146:163.10.1007/s10549-014-2946-2Suche in Google Scholar PubMed

[52] Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 2006;24:4270–6.10.1200/JCO.2006.05.9493Suche in Google Scholar PubMed

[53] Kabel AM. Tumor markers of breast cancer: new prospectives. J Oncol Sci. 2017;3:5–11.10.1016/j.jons.2017.01.001Suche in Google Scholar

[54] Tang Z, Li L, Shen L, Shen X, Ju S, Cong H. Diagnostic value of serum concentration and integrity of circulating cell-free DNA in breast cancer: a comparative study with CEA and CA15-3. Lab Med. 2018;49:323–8.10.1093/labmed/lmy019Suche in Google Scholar PubMed

[55] Tan G, Chu C, Gui X, Li J, Chen Q. The prognostic value of circulating cell-free DNA in breast cancer: a meta-analysis. Medicine (Baltimore). 2018;97:e0197–e0197.10.1097/MD.0000000000010197Suche in Google Scholar PubMed PubMed Central

[56] Weerakoon KG, McManus DP. Cell-free DNA as a diagnostic tool for human parasitic infections. Trends Parasitol. 2016;32:378–91.10.1016/j.pt.2016.01.006Suche in Google Scholar PubMed

[57] Weerakoon KG, Gordon CA, Williams GM, Cai P, Gobert GN, Olveda RM, et al. Droplet digital PCR diagnosis of human schistosomiasis: parasite cell-free DNA detection in diverse clinical samples. J Infect Dis. 2017;216:1611–22.10.1093/infdis/jix521Suche in Google Scholar PubMed

[58] Wang D, Hu Y, Li T, Rong H-M, Tong Z-H. Diagnosis of Pneumocystis jirovecii pneumonia with serum cell-free DNA in non-HIV-infected immunocompromised patients. Oncotarget. 2017;8:71946–53.10.18632/oncotarget.18037Suche in Google Scholar PubMed PubMed Central

[59] Lou X, Hou Y, Liang D, Peng L, Chen H, Ma S, et al. A novel Alu-based real-time PCR method for the quantitative detection of plasma circulating cell-free DNA: sensitivity and specificity for the diagnosis of myocardial infarction. Int J Mol Med. 2015;35:72–80.10.3892/ijmm.2014.1991Suche in Google Scholar PubMed PubMed Central

[60] Bombardieri Stefano MM. Cell-free DNA in the plasma of patients with systemic sclerosis. Clin Rheumatol. 2009;28:1437.10.1007/s10067-009-1245-5Suche in Google Scholar PubMed

[61] Bartoloni E, Ludovini V, Alunno A, Pistola L, Bistoni O, Crinò L, et al. Increased levels of circulating DNA in patients with systemic autoimmune diseases: a possible marker of disease activity in Sjögren’s syndrome. Lupus. 2011;20:928–35.10.1177/0961203311399606Suche in Google Scholar PubMed

[62] Leon SA, Ehrlich GE, Shapiro B, Labbate VA. Free DNA in the serum of rheumatoid arthritis patients. J Rheumatol. 1977;4:139–43.Suche in Google Scholar

[63] Hendy OM, Motalib TA, El Shafie MA, Khalaf FA, Kotb SE, Khalil A, et al. Circulating cell free DNA as a predictor of systemic lupus erythematosus severity and monitoring of therapy. Egypt J Med Hum Genet. 2016;17:79–85.10.1016/j.ejmhg.2015.07.001Suche in Google Scholar

[64] Abdelal IT, Zakaria MA, Sharaf DM, Elakad GM. Levels of plasma cell-free DNA and its correlation with disease activity in rheumatoid arthritis and systemic lupus erythematosus patients. Genet Rheum Dis. 2016;38:295–300.10.1016/j.ejr.2016.06.005Suche in Google Scholar

[65] Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, et al. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet. 2011;80:68–75.10.1111/j.1399-0004.2010.01533.xSuche in Google Scholar PubMed